TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.58
-0.03 (-0.53%)
Aug 10, 2026, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $343.59 million as of August 10, 2026. Its market cap has increased by 129.88% in one year.
Market Cap
343.59M
Enterprise Value
331.72M
1-Year Change
129.88%
Ranking
Category
Stock Price
$5.58
ChartMarket Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has increased from $328.75M to $343.59M, an increase of 4.51%. That is a compound annual growth rate of 0.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 343.59M | -1.48% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sight Sciences | 411.51M |
| Mobia Medical | 406.97M |
| Senseonics Holdings | 371.18M |
| Viemed Healthcare | 370.60M |
| Pacific Biosciences of California | 368.33M |
| 908 Devices | 364.32M |
| CapsoVision | 354.74M |
| Electromed | 349.34M |